A company founded by Rutgers School of Dental Medicine researcher received U.S. Food and Drug Administration approval to begin a phase I clinical trial to treat cancer patients with a therapy based on his discovery that a protein produced by an oral bacterium can kill leukemia and lymphoma cells.
A mobile application developed by researchers Joel Caplan and Leslie Kennedy at Rutgers University aims to protect first responders and healthcare workers by identifying environmental factors that could be contagion vectors among COVID-19 positive cases.
Universities play an important role in inspiring diversity among new generations of entrepreneurs and innovators to improve the innovation ecosystem. Providing underrepresented researchers with access to opportunities and networks can bring the needed change to better reflect the diversity of our nation and to tip the scale toward equity and inclusion in innovation.
Rutgers University and professional services company Accenture join efforts to solve the necessity of face shields and other personal protection equipment for healthcare workers and researchers on the front lines of the COVID-19 pandemic.